Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Media
Activities
Datasets
Search by expertise, name or affiliation
Das Harnblasenkarzinomrezidiv nach BCG-Instillationstherapie. Lokale Therapieoptionen?
Translated title of the contribution
:
Recurrent bladder cancer after BCG instillation therapy. Local therapy options?
J. M. Laturnus
*
, D. Jocham, M. Sommerauer
*
Corresponding author for this work
Clinic of Urology
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Recurrent bladder cancer after BCG instillation therapy. Local therapy options?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Local Therapy
100%
Mycobacterium Bovis BCG
100%
Bladder Cancer
100%
Recurrent Disease
25%
Cystectomy
25%
Neoplasm
12%
Immunotherapy
12%
Gemcitabine
12%
Mitomycin
12%
Docetaxel
12%
Disease Specific Survival
12%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Mycobacterium Bovis BCG
100%
Recurrent Disease
25%
Neoplasm
12%
Docetaxel
12%
Gemcitabine
12%
Mitomycin
12%
Disease Specific Survival
12%